Study Stopped
Not possible due to COVID-19
Lifestyle and Brain Vascular Function
The Effects of a Healthy Lifestyle Intervention on Brain Vascular Function in Older People
1 other identifier
interventional
10
1 country
1
Brief Summary
Cognitive performance is negatively related to an impaired glucose metabolism, possibly due to impairments in brain vascular function. Supported by the statement from the American Heart and Stroke Association that a healthy lifestyle is one of the most effective strategies to protect against cognitive decline, the investigators now hypothesise that healthy lifestyle intervention-induced changes in glucose metabolism cause beneficial effects on brain vascular function thereby improving cognitive performance. The primary objective of this intervention study is thus to evaluate in sedentary older men and women the effect of a 16-week aerobic-based exercise program on cerebral blood flow, as quantified by the non-invasive gold standard magnetic resonance imaging (MRI) perfusion method Arterial Spin Labeling (ASL). Cerebral blood flow is a robust and sensitive physiological marker of brain vascular function. Secondary objectives are to examine effects on glucose metabolism using the homeostatic model assessment for insulin resistance (HOMA-ir) and cognitive performance as assessed with a neurophysiological test battery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2019
CompletedFirst Posted
Study publicly available on registry
January 21, 2020
CompletedStudy Start
First participant enrolled
January 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedApril 19, 2021
April 1, 2021
10 months
December 20, 2019
April 14, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Brain vascular function
Cerebral blood flow as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL)
Baseline (0 weeks)
Brain vascular function
Cerebral blood flow as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL)
After intervention (16 weeks)
Secondary Outcomes (2)
Cognitive performance
Baseline (0 weeks) and after intervention (16 weeks)
Glucose metabolism
Baseline (0 weeks), at the middle (8 weeks) and after intervention (16 weeks)
Other Outcomes (31)
Flow-Mediated Vasodilation (FMD)
Baseline (0 weeks) and after intervention (16 weeks)
Carotid Artery Reactivity (CAR)
Baseline (0 weeks) and after intervention (16 weeks)
Pulse Wave Analysis (PWA)
Baseline (0 weeks) and after intervention (16 weeks)
- +28 more other outcomes
Study Arms (2)
Healthy lifestyle
EXPERIMENTALHealthy lifestyle intervention, which includes physical activity and dietary advice according to the dutch guidelines.
Control
NO INTERVENTIONMaintenance of habitual physical activity and diet
Interventions
The physical activity guidelines for older consist of 150 minutes per week moderate-to-high intensity exercise, two times per week muscle and bone strengthening exercises, which are combined with balance exercises. Additional health benefits can be achieved with a longer exercise duration, frequency and/or intensity. Furthermore, the amount of time sitting should be minimised. The dietary guidelines are described in detail in the so-called "The Wheel of Five". In brief, the circle is divided into four food groups and one beverage group. More than half of the circle is covered by fruits, vegetables, whole grain (containing) breads, cereals and potatoes. A much smaller part is compromised by animal source foods, spreads and cooking fats. Water, tea and coffee without sugar complete the circle.
Eligibility Criteria
You may qualify if:
- BMI between 25-35 kg/m2
- Sedentary (assessed as low physically active using the International Physical Activity Questionnaire)
- Right handedness and footedness
- Fasting plasma glucose \< 7.0 mmol/L
- Fasting serum total cholesterol \< 8.0 mmol/L
- Fasting serum triacylglycerol \< 4.5 mmol/L
- Systolic blood pressure \< 160 mmHg and diastolic blood pressure \< 100 mmHg
- Stable body weight (weight gain or loss \< 3 kg in the past three months)
- Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
- No difficult venipuncture as evidenced during the screening visit
You may not qualify if:
- Current smoker, or smoking cessation \< 12 months
- Diabetic patients
- Familial hypercholesterolemia
- Abuse of drugs
- Consumption of more than 21 alcoholic units/week (men), or more than 14 alcoholic units/week (women)
- Use of dietary supplements known to interfere with the main study outcomes as judged by the principal investigators
- Use medication to treat blood pressure, lipid or glucose metabolism
- Use of an investigational product within another biomedical intervention trial within the previous 1-month
- Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
- Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident
- Contra-indications for MRI imaging, including permanent facial makeup, surgical clips/material in body, metal splinter in eye or claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University Medical Center
Maastricht, Limburg, 6229 ER, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter J. Joris, Dr
Maastricht University
- PRINCIPAL INVESTIGATOR
Ronald P. Mensink, Dr
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2019
First Posted
January 21, 2020
Study Start
January 22, 2020
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
April 19, 2021
Record last verified: 2021-04